Received Feb 27, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | OT |
Vaccination site redness; vaccination site pain; Initial information received on 24-Feb-2026 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (healthcare professional). This case involves Elderly female patient (56.82 kg) who had vaccination site redness and vaccination site pain after receiving INFLUENZA VACCINE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (strength, expiry date and lot number not reported) via unknown route in unknown administration site for Prophylactic vaccination (Immunisation). On an unknown date the patient developed a vaccination site redness (vaccination site erythema) and vaccination site pain (unknown latency). It was reported "Have some itching before next dose due, but overall 90% improvement in symptoms, states did have some redness and pain around injection site when injecting in abdomen with regular needle-redness lasted about 5 days, (states) no worse than what she gets with flu shot. since injection with autoinjector samples in thigh-no redness, just a little bleeding". Action taken was not applicable. It was not reported if the patient received a corrective treatment for the events. At time of reporting, the outcome was Unknown for the events.